Targeting mitochondria for cancer therapy

@article{Fulda2010TargetingMF,
  title={Targeting mitochondria for cancer therapy},
  author={Simone Fulda and Lorenzo Galluzzi and Guido Kroemer},
  journal={Nature Reviews Drug Discovery},
  year={2010},
  volume={9},
  pages={447-464}
}
Mitochondria are the cells' powerhouse, but also their suicidal weapon store. Dozens of lethal signal transduction pathways converge on mitochondria to cause the permeabilization of the mitochondrial outer membrane, leading to the cytosolic release of pro-apoptotic proteins and to the impairment of the bioenergetic functions of mitochondria. The mitochondrial metabolism of cancer cells is deregulated owing to the use of glycolytic intermediates, which are normally destined for oxidative… Expand
Mitochondria in cancer: why mitochondria are a good target for cancer therapy.
TLDR
These organelles, endowed with its own DNA, are a focus of research as possible "culprits" for the malignancy of cancer cells and, importantly, as emerging targets for anticancer therapy. Expand
Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy
TLDR
The roles of mitochondria in cancer with respect to mutations and apoptosis are elaborated and mitochondria-targeting strategies as cancer therapies to enhance the killing of cancer cells are discussed. Expand
Targeting malignant mitochondria with therapeutic peptides.
TLDR
This review discusses anticancer peptides that intersect with pathological changes in the mitochondrion, a key pharmacological target in cancer due to many of the differences that arise between malignant and healthy cells at the level of this ubiquitous organelle. Expand
Restoration of mitochondria function as a target for cancer therapy.
TLDR
This work summarizes the key reasons contributing to mitochondria dysfunction in cancer cells and how restoration of mitochondrial function could be exploited for cancer therapeutics. Expand
Mitochondria-targeted drug delivery system for cancer treatment
TLDR
This comprehensive review focused on the mechanisms of mitochondrial targeting and a variety of strategies to realize the purpose of mitochondria targeting, including that based on the use of lipophilic cations, and mitochondrial targeting signal peptides (MTS) as well as cell-penetrating peptide (CPPs). Expand
Targeting cancer cell mitochondria as a therapeutic approach: recent updates.
TLDR
This review provides an update on recent development in the field of targeting mitochondria and novel compounds that impact mitochondria, glycolysis or both and key challenges in this research area are discussed. Expand
Role of Mitochondria in Cancer Stem Cell Resistance
TLDR
The whole mitochondrial cycle, from its biogenesis to its death, either by mitophagy or by apoptosis, can be targeted by different drugs to reduce mitochondrial fitness, allowing for a restored or increased sensitivity to chemotherapeutic drugs. Expand
Stress‐Related Mitochondrial Components and Mitochondrial Genome as Targets of Anticancer Therapy
TLDR
The achievements and perspectives in the elucidation of the molecular basis for developing mitochondrial‐targeted compounds as potential anticancer agents are reviewed, with special attention to mitochondrial DNA mutations and mitochondrial dysfunction. Expand
Mitochondrial dysfunction in breast cancer
TLDR
This review summarizes the mechanisms that protect the mitochondria of cancer cells against oxidative stress and identifies several transcription factors linked to the mitochondrial unfolded protein response (UPR mt). Expand
Mitochondrial permeability transition as target of anticancer drugs.
TLDR
Observations of the effects of peniocerol (PEN), a sterol isolated from the root of Myrtillocactus geometrizans, at cellular and mitochondrial level evidence that PEN may trigger both the caspase-dependent and caspasesindependent apoptotic pathways, which renders PEN a very interesting compound that could be developed to obtain more effective antiproliferative agents targeting mitochondria for anticancer therapy. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 287 REFERENCES
Mitochondria as therapeutic targets for cancer chemotherapy
TLDR
A variety of experimental therapeutic agents can directly target mitochondria, causing apoptosis induction, and it is possible to design molecules that neutralize inhibitor of apoptosis proteins (IAPs) or heat shock protein 70 (HSP70). Expand
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Mitochondria are the energy factories of the cell and also serve as a checkpoint regulating programmed cell death. Not surprisingly, dysfunctional mitochondria are implicated in a variety of diseasesExpand
Mitochondrial gateways to cancer.
TLDR
Several mechanisms by which mitochondria can contribute to malignant transformation and tumor progression are discussed. Expand
Mitochondria as targets for cancer chemotherapy.
TLDR
How targeting of mitochondria can make tumor cells more susceptible to anticancer treatment is described, and it appears that resistance of most tumors towards treatment can be, at least in part, explained by mitochondrial silencing in cancer cells. Expand
Mitochondria-penetrating peptides.
TLDR
A significant advance is reported in the development of mitochondrial transporters-synthetic cell-permeable peptides that are able to enter mitochondria and demonstrate that mitochondrial localization can be rationally controlled and finely tuned by altering lipophilicity and charge. Expand
Mitochondria in cancer cells: what is so special about them?
TLDR
This review is devoted to the analysis of mitochondrial function in cancer cells, including the mechanisms underlying the upregulation of glycolysis, and how intervention with cellular bioenergetic pathways might make tumor cells more susceptible to anticancer treatment and induction of apoptosis. Expand
Selective targeting of bioactive compounds to mitochondria.
  • M. Murphy
  • Biology, Medicine
  • Trends in biotechnology
  • 1997
TLDR
Because mitochondria play a role in many critical cell processes, mitochondrial targeting has the potential to protect, repair or kill cells selectively, and may become a key tool in the development of gene therapy for mitochondrial DNA diseases. Expand
Disruption of the hexokinase–VDAC complex for tumor therapy
TLDR
The plant hormone methyl jasmonate is shown to disrupt the interaction between human HK and VDAC, causing the inhibition of glycolysis and the induction of MOMP, and this finding may stimulate the development of a novel class of small anticancer compounds that inhibit the HK–VDAC interaction. Expand
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
  • J. Armstrong
  • Biology, Medicine
  • British journal of pharmacology
  • 2007
TLDR
This review discusses mitochondrial drug targeting strategies and a variety of novel mitochondrial drug targets including the electron transport chain, mitochondrial permeability transition, Bcl‐2 family proteins and mitochondrial DNA. Expand
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
TLDR
This review provides an overview of the potential anticancer agents that act by targeting cancer cell metabolism and mitochondria, and also brings us face to face with the emerging opportunities in cancer therapy. Expand
...
1
2
3
4
5
...